We are live on ! Find out more
RTO icon

Rentokil

220 hedge funds and large institutions have $1.57B invested in Rentokil in 2024 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 74 increasing their positions, 86 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed

116% more call options, than puts

Call options by funds: $26M | Put options by funds: $12.1M

14% more funds holding in top 10

Funds holding in top 10: 78 (+1)

0.1% more ownership

Funds ownership: 2.43%2.52% (+0.1%)

5% less funds holding

Funds holding: 232220 (-12)

14% less capital invested

Capital invested by funds: $1.82B → $1.57B (-$245M)

14% less repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 86

22% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 46

Holders
220
Holders Change
-12
Holders Change %
-5.17%
% of All Funds
3.16%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.11%
New
36
Increased
74
Reduced
86
Closed
46
Calls
$26M
Puts
$12.1M
Net Calls
+$14M
Net Calls Change
+$8.33M
Name Holding Trade Value Shares
Change
Change in
Stake
MIS
26
Morningstar Investment Services
Illinois
$10.7M +$3.49M +117,701 +39%
Wells Fargo
27
Wells Fargo
California
$10.4M -$3.44M -116,139 -22%
SI
28
Stephens Inc
Arkansas
$10.1M +$824K +27,836 +7%
PAIM
29
Punch & Associates Investment Management
Minnesota
$9.14M +$2.37M +80,165 +28%
BlackRock
30
BlackRock
New York
$8.83M -$316K -10,663 -3%
IFP
31
Independent Franchise Partners
United Kingdom
$8.62M +$10.2M +345,595 New
BHWM
32
Bar Harbor Wealth Management
New Hampshire
$7.85M +$620K +20,935 +7%
Norges Bank
33
Norges Bank
Norway
$7.82M -$13.8M -467,000 -60%
Barclays
34
Barclays
United Kingdom
$7.55M +$8.97M +303,000 New
PGFC
35
Peapack-Gladstone Financial Corp
New Jersey
$7.55M +$437K +14,745 +5%
RJA
36
Raymond James & Associates
Florida
$7.3M -$1.49M -50,158 -15%
UBS Group
37
UBS Group
Switzerland
$6.7M -$234K -7,912 -3%
NC
38
Nicholas Company
Wisconsin
$6.34M +$1.45M +48,963 +24%
Invesco
39
Invesco
Georgia
$6.27M -$1.39M -46,992 -16%
Lazard Asset Management
40
Lazard Asset Management
New York
$6.03M -$50.1M -1,690,153 -87%
Northern Trust
41
Northern Trust
Illinois
$5.92M -$1.77M -59,756 -20%
AIC
42
Anthracite Investment Company
Texas
$5.35M +$4.31M +145,528 +211%
WC
43
Whitney & Co
New York
$5.22M +$190K +6,401 +3%
MIF
44
Mediolanum International Funds
Ireland
$5.22M +$30.6M +1,033,458 New
Neuberger Berman Group
45
Neuberger Berman Group
New York
$5.18M +$1.1M +37,096 +22%
ICM
46
III Capital Management
Florida
$5.01M +$1.91M +64,580 +47%
SF
47
Synovus Financial
Georgia
$4.74M +$2.65M +89,452 +89%
Marshall Wace
48
Marshall Wace
United Kingdom
$4.65M +$526K +17,766 +11%
MMRF
49
Michelson Medical Research Foundation
California
$4.49M +$5.33M +180,000 New
Stifel Financial
50
Stifel Financial
Missouri
$4.14M -$161K -5,440 -3%

RTO Hedge Fund Activity: Q3 2024 in Review

220 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Rentokil (RTO) for Q3 2024, worth a combined $1.57B — down 14% from $1.82B a quarter earlier.

Sellers outnumbered buyers: 46 funds closed out of RTO and 36 opened new positions — a net loss of 10 holders — while 86 trimmed existing stakes and 74 added.

The largest buyer was River Road Asset Management, opening a new position worth an estimated $52.3M. The largest seller was Lazard Asset Management, cutting an estimated $50.1M.

  • 220 institutional investors held Rentokil (RTO) as of Q3 2024, down from 232 in Q2 2024.
  • Funds reported $1.57B of Rentokil stock for Q3 2024, down 14% quarter-over-quarter.
  • 36 funds opened new Rentokil positions in Q3 2024 and 46 closed out, a net change of -10 holders.
  • The largest Rentokil buyer in Q3 2024 was River Road Asset Management, an estimated $52.3M added.
  • The largest Rentokil seller in Q3 2024 was Lazard Asset Management, an estimated $50.1M sold.

Based on aggregated 13F filings for Q3 2024.